Understanding hypertension through genetic manipulation in mice

Kidney International

Volumn 57, Issue 3, 2000, Pages 863-874

  Cvetkovic, Branimir ^a   Sigmund, Curt D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Animal models; Genetics of disease; Hypertension; Knockout mouse; Mouse models; Renin angiotensin system; Transgenic mouse

Indexed keywords

BRADYKININ B2 RECEPTOR; DOPAMINE RECEPTOR; ENDOTHELIN 1; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; GENE DELETION; GENE OVEREXPRESSION; GENETIC MANIPULATION; HYPERTENSION; KNOCKOUT MOUSE; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC MOUSE;

EID: 0033917514     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.057003863.x     Document Type: Conference Paper

References (103)

1. GORDON JW, RUDDLE FH: Gene transfers into mouse embryos: Production of transgenic mice by pronuclear injection. Methods Enzymol 101:411-433, 1983
2. GORDON JW, RUDDLE FH: Integration and stable germ line transmission of genes injected into mouse pronuclei. 5c/e;ice214:12441246, 19S1
3. SIGMUND CD: Manipulating genes to understand cardiovascular diseases: Major approaches for introducing genes into cells. Hypertension 22:599-607, 1993
4. GROSVELD F, VAN ASSENDELFT GB, GREAVES DR, KOLLIAS G: Position-independent, high-level expression of the human betaglobin gene in transgenic mice. Cell 51:975-985, 1987
5. YANG G, SIGMUND CD: Regulatory elements required for human 1 angiotensinogen expression in HepG2 cells are dispensable in transgenic mice. Hypertension 31:734-740, 1998
6. BRONSON SK, SMITHIES O: Altering mice by homologous recombination using embryonic stem cells. J Biol Cliem 269:27155-27158, 1994
7. EVANS MJ, KAUFMAN MH: Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156, 19S1
8. CAPECCIII MR: Altering the genome by homologous recombination. Science 244:1288-1292, 1989
9. KlMURA S, MULLINS JJ, BUNNEMANN B, METZGER R, HlLGENFELDTU, ZIMMERMANN F.JACOB H, FUXE K, GANTEN D, KALING M: High blood pressure in transgenic mice carrying the rat angiotensinosen gene. EMBO J 11:821-827, 1992
10. OIIKUBO H, KAWAKAMI H, KAKEHI Y, TAKUMI T, ARAI H, YOKOTA Y, IWAI M, TANABE Y, MASU M, HATA J, I\VAO H, OKAMOTO H,
11. YOKOYAMA M, NOMURA T, KATSUKi M, NAKANisiii S: Generation of transgenic mice \vilh elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc Nail Acad Sei USA 87:5153-5157, 1990
12. FUKAMIZU A, SEO MS, HATAE T, YOKOYAMA M, NOMURA T, KATSUKI M, MURAKAMI K: Tissue-specific expression of the human renin gene in transgenic mice. Biochem Biophys Res Com/nun 165:826-832, 19S9
13. SIGMUND CD: Expression of the human renin gene in transgenic mice throughout ontogeny. Pediatr Nephrol 7:639-645, 1993
14. SIGMUND CD, JONES CA, KANE CM, Wu C, LANG JA, GROSS KW: Regulated tissue- and cell-specific expression of the human renin gene in transgenic mice. Circ Res 70:1070-1079, 1992
15. YANG G, MERRILL DC, THOMPSON MW, ROBILLARD JE, SIGMUND CD: Functional expression of the human angiotensinogen gene in transgenic mice. J Bio! Clicm 269:32497-32502, 1994
16. YANG G, SIGMUND CD: Developmental expression of human angiotensinogen in transgenic mice. Am J Pliysiol 274:F932-F939, 1998
17. YAN Y, CHEN R, PITARRESI T, SIGMUND CD, GROSS KW, SEALEY JE, LARAGH JH, CATANZARO DF: Kidney is the only source of human plasma renin in 45-kb human renin transgenic mice. Circ Res 83:1279-1288, 1998
18. HATAE T, TAKIMOTO E, MURAKAMI K, FUKAMIZU A: Comparative studies on species-specific reactivity between renin and angiotensinogen. Mol Cell Biochem 131:43-47, 1994
19. FUKAMIZU A, SUGI.MURA K, TAKIMOTO E, SUGIYAMA F, SEO M-S, TAKAIIASIII S, HATAE T, KAJIWARA N, YAGAMI K, MURAKAMI K: Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human aneiotensinogen eenes.7 Biol Chem 268:1161711621, 1993
20. MERRILL DC,THOMPSON MW, CAR.NEY C, SCHLAGER G, ROBILLARD JE, SIGMUND CD: Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest 97:1047-1055, 1996
21. TAKIMOTO E, ISIIIDA J, SUGIYAMA F, HORIGUCHI H, MURAKAMI K, FUKAMIZU A: Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 274:995-998, 1996
22. YANG G, GRAY TS, SIGMUND CD, CASSELL MD: The angiotensinogen gene is expressed in both astrocytes and neurons in murine central nervous system. Brain Res 817:123-131, 1999
23. DAVISSON RL, YANG G, BELTZ TG, CASSELL MD, JOHNSON AK, SIGMUND CD: The brain renin-angiotensin system contributes to the hypertension exhibited by mice containing both human renin and human angiotensinogen transgenes. Circ Res 83:1047-1058, 1998
24. DING Y, DAVISSON RL, HARDY DO, Znu L-J, MERRILL DC, CATTERALL JF, SIGMUND CD: The kidney androgen-regulated protein (KAP) promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice./ Biol Cliem 272:28142-28148,1997
25. DAVISSON RL, DING Y, STEC DE, CATTERALL JF, SIGMUND CD: Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Pliysiol Genome 1:3-9, 1999
26. MULLINS JJ, PETERS J, GANTEN D: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344:541544, 1990
27. GANTEN D, WAGNER J, ZEH K, KOELLER M, BADER M, MICHEL JB, PAUL M, ZIMMERMANN F, RUF P, HILGENFELD U, GANTEN U, KALING M, BACHMANN S, MULLINS JJ, MURAKAMI K: Speciesspecificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc Natl Acad Sei USA 89: 7806-7810, 1992
28. PICCINI N, KNOPF JL, GROSS KW: A DNA polymorphism, consistent with gene duplication, correlates with high renin levels in the mouse submaxillary gland. Cell 30:205-213, 1982
29. ABEL KJ, GROSS KW: Close physical linkage of the murine Ren-1 and Ren-2 loci. Nucleic Acids Res 16:2111-2126, 1988
30. KIM HS, KREGE JH, KLUCKMAN KD, HAGAMAN JR, HODGIN JB, BEST CF, JENNETTE JC, COFFMAN TM, MAEDA N, SMITHIES O: Genetic control of blood pressure and the angiotensinogen locus. Proc Nail Acad Sei USA 92:2735-2739, 1995
31. TANIMOTO K, SUGIYAMA F, GOTO Y, ISIIIDA J, TAKIMOTO E, YAGAMI K, FUKAMIZU A, MURAKAMI K: Angiotensinogen-deficient mice with hypotension. J Biol Chem 269:31334-31337, 1994
32. DAVISSON RL, KIM HS, KREGE JH, LAGER DJ, SMITHIES O, SIGMUND CD: Complementation of reduced survival, hypotension and renal abnormalities in angiotensinogen deficient mice by the human renin and human angiotensinogen genes. J Clin Invest 99:1258-1264, 1997
33. ISIIIDA J, SUGIYAMA F, TANIMOTO K, TANIGUCIII K, SYOUJI M, TAKIMOTO E, HORIGUCHI H, MURAKAMI K, YAGAMI K, FUKAMIZU A: Rescue of angiotensinogen-knockout mice. Biochem Biophys Res Commun 252:610-616, 1998
34. OKUBO S, NIIMURA F, MATSUSAKA T, FOGO A, HOGAN BL, IcinKAWA I: Angiotensinogen gene null-mutant mice lack homeostatic regulation of glomerular filtration and tubular reabsorption. Kidney bit 53:617-625, 1998
35. KREGE JH, JOHN SWM, LANGENBACII LL, HODGIN JB, HAGAMAN , JR, BACHMAN ES, JENNETTE JC, O'BRIEN DA, SMITHIES O: Malefemale differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146-148, 1995
36. ESTHER CR JR, HOWARD TE, MARINO EM, GODDARD JM, CAPECCHI MR, BERNSTEIN KE: Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74:953-965, 1996
37. KREGE JH, KIM HS, MOYER JS, JENNETTE JC, PENG L, HILLER SK, SMITHIES O: Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 29:150-157, 1997
38. ESTHER CR, MARINO EM, HOWARD TE, MACHAUD A, CORVOL P, CAPECCHI MR, BERNSTEIN KE: The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest 99:2375-2385, 1997
39. SUGAYA T, NlSIIIMATSU S, TANIMOTO K, TAKIMOTO E, YAMAGISHI T, IMAMURA K, GOTO S, IMAIZUMI K, HISADA Y, OTSUKA A, UCIIIDA H, SUGIURA M, FUKUTA K, FUKAMIZU A, MURAKAMI K: Angiotensin II type la receptor-deficient mice with hypotension and hyperreninemia. J Biol Cliem 270:18719-18722, 1995
40. ITO M, OLIVERIO MI, MANNON PJ, BEST CF, MAEDA N, SMITHIES O, COFF.MAN T: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sei USA 92:35213525, 1995
41. OLIVERIO MI, BEST CF, KIM H-S, ARENDSHORST WJ, SMITHIES O, COFFMAN TM: Effects of angiotensin II in mice lacking AT1A angiotensin receptors: A role for ATI B receptors in blood pressure regulation. Am J Pliysiol 272:F515-F520, 1997
42. BURSON JM, AGUILERA G, GROSS KW, SIGMUND CD: Differential expression of angiotensin receptor 1A and IB in mouse. Am J Pliysiol 267:E260-E267, 1994
43. SCIINER.MANN JB, TRAYNOR T, YANG T, HUANG YG, OLIVERIO MI, COFFMAN T, BRIGGS JP: Absence of tubuloglomerular feedback responses in ATI A receptor-deficient mice. Am J Pliysiol 273: F315-F320, 1997
44. KIIIARA M, UME.MURA S, SUGAYA T, TOYA Y, YABANA M, KOBAYASIII S, TAMURA KADOTA T, KISIIIDA R, MURAKAMI K, FUKAMIZU A, ISHII M: Expression of neuronal type nitric oxide synthase and renin in the juxtaglomerular apparatus of angiotensin type-la receptor gene-knockout mice. Kidney lut 53:1585-1593, 1998
45. CIIEN XM, Li WG, YOSIIIDA H, TSUCHIDA S, NISHIMURA H, TAKEMOTO F, OKUBO S, Foco A, MATSUSAKA T, ICIIIKAWA I: Targeting deletion of angiotensin type IB receptor gene in the mouse. Am J Pliysiol 41:F299-F304, 1997
46. TSUCHIDA S, MATSUSAKA T, CIIEN X, OKUBO S, NIIMURA F, NISHIMURA H, FOGO A, UTSUNOMIYA H, INAGAMI T, ICIIIKAWA I: Murine double nullizygotes of the angiotensin type 1A and IB receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 101:755-760, 1998
47. OLIVERIO MI, KIM HS, ITO M, LE T, AUDOLY L, BEST CF, HILLER S, KLUCKMAN K, MAEDA N, SMITHIES O, COFFMAN TM: Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both ATI A and AT1B receptors for angiotensin II. Proc Nat! Acad Sei USA 95:15496-15501, 1998
48. HEIN L, BARSH GS, PRATT RE, DZAU VJ, KOBILKA BK: Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377:744-747, 1995
49. ICIIIKI T, LABOSKY PA, SHIOTA C, OKUYAMA S, IMAGAWA Y, FOGO A, NIIMURA F, ICIIIKAWA I, HOGAN BLM, INAGAMI T: Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377:748-750, 1995
50. CLARK AF, SHARP MF, MORLEY SD, FLEMING S, PETERS J, MULLINS JJ: Renin-1 is essential for normal renal juxtaglomerular cell granulation and macula densa morphology. J Biol Cliem 272:1818518190, 1997
51. SHARP MG, FETTES D, BROOKER G, CLARK AF, PETERS J, FLEMING S, MULLINS JJ: Targeted inactivation of the Ren-2 gene in mice. Hypertension 28:1126-1131, 1996
52. IGNARRO LJ, BUGA GM, WOOD KS, BYRNS RE, CHAUDHURI G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sei USA 84:92659269, 1987
53. PALMER RM, FERRIGE AG, MONCADA S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526, 1987
54. LAUBACII VE, SHESELY EG, SMITHIES O, SHERMAN PA: Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sei USA 92:10688-10692, 1995
55. HUANG PL, DAWSON TM, BREDT DS, SNYDER SH, FISHMAN MC: Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75:1273-1286, 1993
56. SHESELY EG, MAEDA N, KIM HS, DESAI KM, KREGE JH, LAUBACII VE, SHERMAN PA, SESSA WC, SMITHIES O: Elevated blood près-, sures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sei USA 93:13176-13181, 1996
57. Runic RD, SHESELY EG, MAEDA N, SMITHIES O, SEGAL SS, SESSA WC: Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101:731-736, 1998
58. FARACI FM, SIGMUND CD, SIIESELY EG, MAEDA N, HEISTAD DD: Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Pliysiol 274:H564-H570, 1998
59. SAITOII S, SCICLI AG, PETERSON E, CARRETERO OA: Effect of inhibiting renal kallikrein on prostaglandin E2, water, and sodium excretion. Hypertension 25:1008-1013, 1995
60. MATTSON DL, COWLEY AW JR: Kinin actions on renal papillary blood flow and sodium excretion. Hypertension 21:961-965,1993
61. ALFIE ME, SIGMON DH, POMPOSIELLO SI, CARRETERO OA: Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors. Hypertension 29:483-487, 1997
62. ALFIE ME, YANG XP, HESS F, CARRETERO OA: Salt-sensitive hypertension in bradykinin B2 receptor knockout mice. Biocliem Biopliys Res Commun 224:625-630, 1996
63. MADEDDU P, MILIA AF, SALIS MB, GASPA L, GROSS W, LIPPOLDT A, EMANUELI C: Renovascular hypertension in bradykinin B2receptor knockout mice. Hypertension 32:503-509, 1998
64. JOSE PA, RAYMOND JR, BATES MD, APERIA A, FELDER RA, CAREY RM: The renal dopamine receptors. J Am Soc Neplirol 2:12651278, 1992
65. SANADA H, YAO L, JOSE PA, CAREY RM, FELDER RA: Dopamine D3 receptors in rat juxtaglomerular cells. Clin Exp Hypertens 19:93-105, 1997
66. ALBRECHT FE, DRACO J, FELDER RA, PRINTZ MP, EISNER GM, ROBILLARD JE, SIBLEY DR, WESTPHAL HJ, JOSE PA: Role of the D l A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 97:2283-2288, 1996
67. Asico LD, LADINES C, Fucus S, ACCILI D, CAREY RM, SEMERARO C, POCCHIARI F, FELDER RA, EISNER GM, JOSE PA: Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest 102:493-498, 1998
68. BILDER GE, SCHOFIELD TL, BLAINE EH: Release of atrial natriuretic factor: Effects of repetitive stretch and temperature. Am J Pliysiol 251:F817-F821, 19S6
69. BLAINE EH, HEINEL LA, SCIIORN T\V, MARSH EA, WIHNNERY MA: The character of the atrial natriuretic response: Pressure and volume effects. J Hypertens (Suppl 4):S17-S24, 1986
70. HARRIS PJ, THOMAS D, MORGAN TO: Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature 326:697-698, 1987
71. JOHN SWM, KREGE JH, OLIVER PM, HAGAMAN JR, HODGIN JB, PANG SC, FLYNN TG, SMITHIES O: Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679-681, 1995
72. MELO LG, VERESS AT, CIIONG CK, PANG SC, FLYNN TG, SONNENBERG H: Salt-sensitive hypertension in ANP knockout mice: Potential role of abnormal plasma renin activity. Am J Pliysiol 274:R255-R261, 1998
73. LOPEZ MJ, WONG SKF, KISIIIMOTO I, DUBOIS S, MACH V, FRIESEN J, GARBERS DL, BEUVE A: Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378:65-68, 1995
74. OLIVER PM, Fox JE, KIM R, ROCKMAN HA, KIM HS, REDDICK RL, PANDEY KN, MILGRAM SL, SMITHIES O, MAEDA N: Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Nail Aeail Sei USA 94:14730-14735, 1997
75. YANAGISAWA M, INOUE A, ISHIKAWA T, KASUYA Y, KIMURA S, KUMAGAYE S, NAKAJIMA K, WATANABE TX, SAKAKIBARA S, GOTO K: Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sei USA 85:6964-6967, 1988
76. YANAGISAWA M, KURIHARA H, KIMURA S, TOMOBE Y, KOBAYASHI M, MITSUI Y, YAZAKI Y, GOTO K, MASAKI T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988
77. KURIHARA Y, KURIHARA H, SUZUKI H, KODAMA T, MAEMURA K, NAGAI R, ODA H, KUWAKI T, CAO \V-H, KAMADA N, JISHAGE K, OUCHI Y, AZUMA S, TOYODA Y, ISHIKAWA T, KUMADA M, YAZAKI Y: Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368:703-710, 1994
78. MORITA H, KURIHARA H, KuRIIIARA Y, SlIINDO T, KUWAKI T, KUMADA M, YAZAKI Y: Systemic and renal response to salt loading in endothelin-1 knockout mice. J Cardiovasc Pharmacol 31(Suppl 1):S557-S560, 1998
79. HOCHER B, TIIONE-REINEKE C, ROHMEISS P, SCIIMAGER F, SLOWINSKI T, BURST SIEGMUND F, QUERTERMOUS T, BAUER C, NEUMAVER HH, SCIILEUXING WD, THEURING F: Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99:1380-1389, 1997
80. KURO-O M, HANAOKA K, HIROI Y, NOGUCHI T, FUJIMORI Y, TAKEWAKi S, HAYASAKA M, KATOII H, MIYAGISHI A, NAOAI R, YAZAKI Y, NABESIIIMA O: Salt-sensitive hypertension in transgenic mice overe.xpressing Na(+)-proton exchanger. Circ Res 76:148-153,1995
81. SCIIULTHEIS PJ, CLARKE LL, MENETON P, MILLER ML, SOLEIMANI M, GAWENIS LR, RIDDLE TM, DUFFY JJ, DOETSCIIMAN T, WANG T, GIEBISCH G, ARONSON PS, LORENZ JN, SHULL GE: Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H exchanger. Nat Genet 19:282-285, 1998
82. SCIIULTHEIS PJ, CLARKE LL, MENETON P, HARLINE M, BOIVIN GP, STEMMERMANN G, DUFFY JJ, DOETSCIIMAN T, MILLER ML, SHULL GE: Targeted disruption of the murine Na+/H exchanger isoform 2 gene causes reduced viability of gastric parietal cells and loss of net acid secretion. J Clin Invest 101:1243-1253, 1998
83. STEC DE, SIGMUND CD: Modifiable gene expression in kidney: Kidney-specific deletion of a target gene via the cre-loxP system. Exp Nephrol 6:568-575, 1998
84. CIIEN J, KUBALAK SW, CHIEN KR: Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. Development 125:1943-1949, 199S
85. BRONSON SK, PLAEIIN EG, KLUCKMAN KD, HAGAMAN JR, MAEDA N, SMITHIES O: Single-copy transgenic mice with chosen-site integration. Proc Nail Acad Sei USA 93:9067-9072, 1996
86. HATADA S, KUZIEL W, SMITHIES O, MAEDA N: The influence of chromosomal location on the expression of two transgenes in mice. J Biol Cliem 274:948-955, 1999
87. KILBY NJ, SNAITII MR, MURRAY JAH: Site-specific recombinases: Tools for genome engineering. Trends Genet 9:413-421, 1994
88. LAKSO M, SAUER B, MOSINGER B, LEE EJ, MANNING RW, Yu S-H, MULDER KL, WESTPIIAL H: Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Nail Acad Sei USA 89:6232-6236, 1992
89. Gu H, MARTII JD,ORBAN PC, MOSSMAN H, RAJEWSKY K: Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265:103-106, 1994
90. PLUCK A: Conditional mutagenesis in mice: The Cre/loxP recombination system. 1m J Exp Patlwl 77:269-278, 1996
91. FURTH PA, ST. ONCE L, BöGER H, GRUSS P, GOSSEN M, KISTNER A, BUJARD H, HENNIGHAUSEN L: Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Nail Acad Sei USA 91:9302-9306, 1994
92. No D, YAOTP, EVANS RM: Ecdysonc-inducible gene expression in mammalian cells and transcenic mice. Proc NatlAcad Sei USA 93:3346-3351, 1996
93. KISTNER A, GOSSEN M, ZIMMERMANN F, JERECIC J, ULLMER C, LUBBERT H, BUJARD H: Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sei USA 93:10933-10938, 1996
94. GOSSEN M, FREUNDLIB S, BENDER G, MULLER G, HILLEN W, BUJARD H: Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766-1769, 1995
95. DANIELIAN PS, MUCCINO D, ROWITCII DH, MICHAEL SK, McMAHON AP: Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Cnrr Biol 8:1323-1326, 1998
96. CANO A: Characterization of the rat NHE3 promoter. Am J Pltys/o/271:F629-F636, 1996
97. EMERT MP, SORENSON CM, BASILE DP, ROGERS JG, HAMMERMANMR, BILLADELLO JJ: The human plasminogen activator inhibitor type 1 gene promoter targets to kidney. Am J Plivsiol 274:F405F412, f99S
98. SEPULVEDA AR, HUANG SL, LEBOVITZ RM, LIEBER.MAN MW: A 346-base pair region of the mouse gamma-glutamyl transpeptidase type II promoter contains sufficient cis-acting elements for kidney-restricted expression in transgenic mice. J Biol Chem 272:11959-11967, 1997
99. IGARASHI P, WIIYTE DA, Li K, NAGAMI GT: Cloning and kidney cell-specific activity of the promoter of the murine renal Na-KCl cotransporter gene. / Biol Chem 271:9666-9674, 1996
100. BLAU S, DALY L, FIENBERG A, TEITELMAN G, EHRLICH ME: DARPP-32 promoter directs transgene expression to renal thick ascending limb of loop of Henle. Am J Physiol 269:F564-F570, 1995
101. STRICKLETT PK, NELSON RD, KOIIAN DE: Targeting collecting tubules using the aquaporin-2 promoter. Exp Nephrol 7:67-74, 1999
102. SAUR KE, DANIELS BP, HANSPAL M: Identification of the proximal erythroid promoter region of the mouse anion exchanger gene. Blood 88:4500-4509, 1996
103. KANEKO T, TAKENAKA M, OKABE M, YOSHIMURA Y, YAMAUCHI A, HORIO M, KWON HM, HANDLER JS, IMAI E: Osmolarity in renal medulla of transgenic mice regulates transcription via 5'flanking region of canine BGT1 gene. Am J Pliysiol 272:F610F616, 1997